1.
Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease
by Pirola, Carlos Jose
Gut, 2013-09, Vol.62 (9), p.1356-1363
2.
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
by Syn, Wing-Kin
Gut, 2012-09, Vol.61 (9), p.1323-1329
3.
MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway
by Wu, Heng Heng
Gut, 2015-08-17, Vol.65 (11), p.1850-1860
4.
The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis
by Wang, Guo-Xiao
Nature medicine, 2014-12, Vol.20 (12), p.1436-1443
5.
G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis
by Wei, Tao
Cancer letters, 2016, Vol.382 (2), p.195-202
6.
Signals from dying hepatocytes trigger growth of liver progenitors
by Jung, Youngmi
Gut, 2010-05, Vol.59 (5), p.655-665
7.
Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice
by Lee, Jaemin
Nature medicine, 2016-09, Vol.22 (9), p.1023-1032
8.
Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
by Hallsworth, Kate
Gut, 2011-09, Vol.60 (9), p.1278-1283
9.
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
by Kawano, Yuki
Journal of gastroenterology, 2013-02-09, Vol.48 (4), p.434-441
10.
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
by European Association for the Study of Diabetes (EASD)
Diabetologia, 2016-04-07, Vol.59 (6), p.1121-1140
11.
Omega-3 Fatty Acids, Hepatic Lipid Metabolism, and Nonalcoholic Fatty Liver Disease
by SCORLETTI, E
Annual review of nutrition, 2013, Vol.33 (1), p.231-248
12.
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
by Matthews, V. B
Diabetologia, 2010-08-11, Vol.53 (11), p.2431-2441
13.
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis
by Berasain, Carmen
Journal of gastroenterology, 2013-12-10, Vol.49 (1), p.9-23
14.
Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Inde...
by Jones, Helen
The journal of clinical endocrinology and metabolism, 2012-10, Vol.97 (10), p.3709-3716
15.
Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently
by Beilfuss, Anja
Gut, 2015-05, Vol.64 (5), p.791-799
16.
17.
Pathology of nonalcoholic fatty liver disease
by YEH, Matthew M
American journal of clinical pathology, 2007, Vol.128 (5), p.837-847
18.
Lack of SIRT1 (Mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1+/− Mice: A Role of Lipid Mobilization and Inflammation
by Xu, Fen
Endocrinology (Philadelphia), 2010-06, Vol.151 (6), p.2504-2514
19.
Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice
by Furusho, Hisako
Journal of gastroenterology, 2013-01-11, Vol.48 (11), p.1259-1270
20.
Resveratrol improves health and survival of mice on a high-calorie diet
by Ramaswamy, Sharan
Nature, 2006-11-16, Vol.444 (7117), p.337-342
